全文获取类型
收费全文 | 751篇 |
免费 | 41篇 |
国内免费 | 26篇 |
专业分类
儿科学 | 7篇 |
妇产科学 | 7篇 |
基础医学 | 99篇 |
口腔科学 | 7篇 |
临床医学 | 44篇 |
内科学 | 119篇 |
皮肤病学 | 12篇 |
神经病学 | 90篇 |
特种医学 | 4篇 |
外科学 | 28篇 |
综合类 | 43篇 |
预防医学 | 30篇 |
眼科学 | 2篇 |
药学 | 276篇 |
中国医学 | 18篇 |
肿瘤学 | 32篇 |
出版年
2023年 | 4篇 |
2022年 | 10篇 |
2021年 | 17篇 |
2020年 | 36篇 |
2019年 | 14篇 |
2018年 | 23篇 |
2017年 | 23篇 |
2016年 | 20篇 |
2015年 | 23篇 |
2014年 | 44篇 |
2013年 | 60篇 |
2012年 | 58篇 |
2011年 | 55篇 |
2010年 | 41篇 |
2009年 | 45篇 |
2008年 | 54篇 |
2007年 | 29篇 |
2006年 | 30篇 |
2005年 | 18篇 |
2004年 | 23篇 |
2003年 | 31篇 |
2002年 | 20篇 |
2001年 | 11篇 |
2000年 | 12篇 |
1999年 | 9篇 |
1998年 | 1篇 |
1997年 | 12篇 |
1996年 | 7篇 |
1995年 | 8篇 |
1994年 | 2篇 |
1993年 | 7篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 4篇 |
1989年 | 7篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 6篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 3篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 6篇 |
1976年 | 2篇 |
1975年 | 3篇 |
排序方式: 共有818条查询结果,搜索用时 15 毫秒
31.
For over 30 years, scientists have been investigating the phenomenon of pain suppression upon exposure to unconditioned or conditioned stressful stimuli, commonly known as stress-induced analgesia. These studies have revealed that individual sensitivity to stress-induced analgesia can vary greatly and that this sensitivity is coupled to many different phenotypes including the degree of opioid sensitivity and startle response. Furthermore, stress-induced analgesia is influenced by age, gender, and prior experience to stressful, painful, or other environmental stimuli. Stress-induced analgesia is mediated by activation of the descending inhibitory pain pathway. Pharmacological and neurochemical studies have demonstrated involvement of a large number of neurotransmitters and neuropeptides. In particular, there are key roles for the endogenous opioid, monoamine, cannabinoid, γ-aminobutyric acid and glutamate systems. The study of stress-induced analgesia has enhanced our understanding of the fundamental physiology of pain and stress and can be a useful approach for uncovering new therapeutic targets for the treatment of pain and stress-related disorders. 相似文献
32.
Iman Mahlooji Maryam Shokri Rana Manoochehri Mohammad Mahboubi-Rabbani Elham Rezaee Sayyed Abbas Tabatabai 《Archiv der Pharmazie》2020,353(8):2000052
Soluble epoxide hydrolase (sEH) inhibitors are effective in reducing blood pressure, inflammation, and pain in a number of mammalian disease models. As most classical urea-based sEH inhibitors suffer from poor solubility and pharmacokinetic properties, the development of novel sEH inhibitors with an improved pharmacokinetic specification has received a great deal of attention. In this study, a series of amide-based sEH inhibitors bearing a phthalimide ring as the novel secondary pharmacophore (P2) was designed, synthesized, and evaluated. Docking results illustrated that the amide group as the primary pharmacophore (P1) was placed at a suitable distance from the three key amino acids (Tyr383, Tyr466, and Asp335) for an effective hydrogen bonding. In agreement with these findings, most of the newly synthesized compounds demonstrated moderate to high sEH inhibitory activities, relative to 12-(3-adamantan-1-yl-ureido)dodecanoic acid as the reference standard. Compound 12e with a 4-methoxybenzoyl substituent exhibited the highest sEH inhibitory activity, with an IC50 value of 1.06 nM. Moreover, the ADME properties of the compounds were evaluated in silico, and the results revealed appropriate predictions. 相似文献
33.
34.
K. Bácsi J. P. Kósa Á. Lazáry B. Balla H. Horváth A. Kis Z. Nagy I. Takács P. Lakatos G. Speer 《Osteoporosis international》2009,20(4):639-645
Summary LCT 13910 CC genotype is associated with lactose intolerance, a condition often resulting in reduced milk intake. Women with
the CC genotype were found to have decreased serum calcium and reduced bone mineral density.
Introduction The CC genotype of the 13910 C/T polymorphism of the LCT gene is linked to lactose intolerance and low calcium intake.
Methods We studied 595 postmenopausal women, including 267 osteoporotic, 200 osteopenic, and 128 healthy subjects. Genotyping, osteodensitometry,
and laboratory measurements were carried out.
Results Frequency of aversion to milk consumption was 20% for CC genotype and 10% for TT + TC genotypes (p = 0.03). The albumin-adjusted serum calcium was 2.325 ± 0.09 mmol/L for CC genotype and 2.360 ± 0.16 mmol/L for TT + TC genotypes
(p = 0.031). Bone mineral density (BMD; Z score) was lower in the CC than TT + TC genotypes, respectively, at the radius (0.105 ± 1.42 vs 0.406 ± 1.32; p = 0.038), at the total hip (−0.471 ± 1.08 vs −0.170 ± 1.09; p = 0.041), and at the Ward’s triangle (−0.334 ± 0.87 vs −0.123 ± 0.82; p = 0.044).
Conclusion LCT 13910 C/T polymorphism is associated with decreased serum calcium level and lower BMD in postmenopausal women.
Péter Lakatos and Gábor Speer contributed equally to this work. 相似文献
35.
Xu-Dong Kong Shuguang Yuan Lin Li She Chen Jian-He Xu Jiahai Zhou 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(44):15717-15722
Optically pure epoxides are essential chiral precursors for the production of (S)-propranolol, (S)-alprenolol, and other β-adrenergic receptor blocking drugs. Although the enzymatic production of these bulky epoxides has proven difficult, here we report a method to effectively improve the activity of BmEH, an epoxide hydrolase from Bacillus megaterium ECU1001 toward α-naphthyl glycidyl ether, the precursor of (S)-propranolol, by eliminating the steric hindrance near the potential product-release site. Using X-ray crystallography, mass spectrum, and molecular dynamics calculations, we have identified an active tunnel for substrate access and product release of this enzyme. The crystal structures revealed that there is an independent product-release site in BmEH that was not included in other reported epoxide hydrolase structures. By alanine scanning, two mutants, F128A and M145A, targeted to expand the potential product-release site displayed 42 and 25 times higher activities toward α-naphthyl glycidyl ether than the wild-type enzyme, respectively. These results show great promise for structure-based rational design in improving the catalytic efficiency of industrial enzymes for bulky substrates.Optically pure epoxides and the corresponding vicinal diols are valuable chiral building blocks for the production of pharmaceutically active compounds and other fine chemicals (1). Existing approaches for preparing enantiopure epoxides and diols include the asymmetric epoxidation or dihydroxylation of olefin substrates and the resolution of racemic epoxides. These reactions can be accomplished with either chemical catalysts such as chiral salen cobalt complexes and porphyrin manganese adducts or biocatalysts such as monooxygenases and epoxide hydrolases (EHs) (2–4). In the past two decades, EHs have received much attention because they are cofactor-independent enzymes that are “easy to use” for catalyzing the hydrolysis of racemic epoxides to yield highly enantiopure epoxides and vicinal diols (1, 5, 6). However, application of EHs in laboratory and industry was often hindered by their narrow substrate scope, low enantioselectivity, and regioselectivity, or product inhibition (7, 8).Many protein-engineering efforts have been made to overcome these drawbacks (9, 10). For example, directed evolution by error-prone PCR or DNA shuffling has been used to enhance the activity and enantioselectivity of EHs (11–13). Structure-guided mutagenesis also generated a few EH variants with improved catalytic performance (14–16). The strategy of iterative Combinatorial Active Site-Saturation Test (CAST) combines the rational approach and directed evolution to yield high-quality and small focused mutant libraries for screening EHs with better enantioselectivity (7, 17). By mutating residues at the substrate-binding site, the substrates of EHs have been expanded to include cyclic meso-epoxides, phenyl glycidyl ether (PGE) derivatives, and other styrene oxide-like analogs (18, 19). However, the catalytic efficiency of EH is still not satisfactory for bulky epoxide substrates including precursors of (S)-propranolol, (S)-alprenolol, and other β-adrenergic receptor blocking drugs (20, 21).In this work, we select BmEH, an EH cloned from Bacillus megaterium ECU1001, to expand its substrate scope for bulky pharmaco substrate α-naphthyl glycidyl ether (NGE). This enzyme is a potential industrial biocatalyst because it has unusual (R)-enantioselectivity and resolves ortho-substituted PGEs and para-nitrostyrene oxide with excellent enantiomeric ratios (E > 200) (22). We first identified the active tunnel of BmEH by solving its crystal structure complexed with a substrate analog phenoxyacetamide (POA) and analyzing the routes of substrate entry and product release by mass spectrum analysis. Alanine scanning experiments targeted to the potential product-release site of BmEH resulted in two variants, F128A and M145A, with efficient bioresolution abilities on NGE. Further kinetic measurements and structural analysis showed that M145A has much higher activity for the transition state intermediate formation, whereas both mutants exhibited expanded product-release site. The M145A BmEH variant has been successfully applied for the preparation of (S)-propranolol on a gram scale. The engineering of the potential product-release site described herein should have great promise for structure-based rational design of better industrial enzymes. 相似文献
36.
37.
Keiko Kondo Katsutaro Morino Yoshihiko Nishio Motoyuki Kondo Keiko Nakao Fumiyuki Nakagawa Atsushi Ishikado Osamu Sekine Takeshi Yoshizaki Atsunori Kashiwagi Satoshi Ugi Hiroshi Maegawa 《Metabolism: clinical and experimental》2014
Objective
The beneficial effects of fish and n-3 polyunsaturated fatty acids (PUFAs) consumption on atherosclerosis have been reported in numerous epidemiological studies. However, to the best of our knowledge, the effects of a fish-based diet intervention on endothelial function have not been investigated. Therefore, we studied these effects in postmenopausal women with type 2 diabetes mellitus (T2DM).Materials/Methods
Twenty-three postmenopausal women with T2DM were assigned to two four-week periods of either a fish-based diet (n-3 PUFAs ≧ 3.0 g/day) or a control diet in a randomized crossover design. Endothelial function was measured with reactive hyperemia using strain-gauge plethysmography and compared with the serum levels of fatty acids and their metabolites. Endothelial function was determined with peak forearm blood flow (Peak), duration of reactive hyperemia (Duration) and flow debt repayment (FDR).Results
A fish-based dietary intervention improved Peak by 63.7%, Duration by 27.9% and FDR by 70.7%, compared to the control diet. Serum n-3 PUFA levels increased after the fish-based diet period and decreased after the control diet, compared with the baseline (1.49 vs. 0.97 vs. 1.19 mmol/l, p < 0.0001). There was no correlation between serum n-3 PUFA levels and endothelial function. An increased ratio of epoxyeicosatrienoic acid/dihydroxyeicosatrienoic acid was observed after a fish-based diet intervention, possibly due to the inhibition of the activity of soluble epoxide hydrolase.Conclusions
A fish-based dietary intervention improves endothelial function in postmenopausal women with T2DM. Dissociation between the serum n-3 PUFA concentration and endothelial function suggests that the other factors may contribute to this phenomenon. 相似文献38.
《Environmental toxicology and pharmacology》2014,37(3):989-996
Benzo[a]pyrene (BaP) is a human carcinogen requiring metabolic activation prior to reaction with DNA. Cytochrome P450 (CYP) 1A1 is the most important hepatic and intestinal enzyme in both BaP activation and detoxification. CYP1A2 is also capable of oxidizing BaP, but to a lesser extent. The induction of CYP1A1/2 by BaP and/or β-naphthoflavone in liver and small intestine of rats was investigated. Both BaP and β-naphthoflavone induced CYP1A expression and increased enzyme activities in both organs. Moreover, the induction of CYP1A enzyme activities resulted in an increase in formation of BaP–DNA adducts detected by 32P-postlabeling in rat liver and in the distal part of small intestine in vivo. The increases in CYP1A enzyme activity were also associated with bioactivation of BaP and elevated BaP–DNA adduct levels in ex vivo incubations of microsomes of both organs with DNA and BaP. These findings indicate a stimulating effect of both compounds on BaP-induced carcinogenesis. 相似文献
39.
Stephen B. Lewis Regina Wolper Yueh‐Yun Chi Lynn Miralia Yong Wang Cui Yang Gerry Shaw 《Journal of neuroscience research》2010,88(7):1475-1484
By using two different approaches, ubiquitin C‐terminal hydrolase 1 (UCHL1) was identified as a potential cerebrospinal fluid (CSF) biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage (ASAH) and presumably other CNS damage and disease states. Appropriate antibodies and a sensitive ELISA were generated, and the release of UCHL1 into CSF was compared with that of pNF‐H and S100β in a cohort of 30 ASAH patients. Both UCHL1 and pNF‐H showed persistent release into CSF in almost all patients in the second week postaneurysmal rupture (AR), and S100β levels rapidly declined to baseline levels in 23 of 30 patients. Seven of thirty patients showed persistently elevated S100β levels over the first 5 days post‐AR and also had relatively higher levels of pNF‐H and UCHL1 higher compared with the rest. These patients proved to have very poor outcomes, with 6 of 7 expiring. Patients who did reduce S100β levels tended to have a better outcome if pNF‐H and UCHL1 levels were also lower, and elevated UCHL1 levels in the second week post‐AR were particularly predictive of poor outcome. Acute coordinated releases of large amounts of UCHL1, pNF‐H, and S100β in 16 of 30 patients were observed, suggesting sudden loss of brain tissues associated with secondary events. We conclude that measurement of the CSF levels of these proteins reveals details of ASAH progression and recovery and predicts patient outcome. © 2010 Wiley‐Liss, Inc. 相似文献
40.
Fabiola Voznika Merriam Zun‐Yi Wang Cecilia J. Hillard Kara L. Stuhr Dale E. Bjorling 《BJU international》2011,108(7):1145-1149
Study Type – Aetiology (case series) Level of Evidence 4